BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2576941)

  • 1. Screening for medullary thyroid cancer in France: a national effort. French Medullary Study Group (GETC).
    Calmettes C; Chaventre A; Feingold N; Franc B; Guliana JM
    Henry Ford Hosp Med J; 1989; 37(3-4):120-1. PubMed ID: 2576941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of sporadic and hereditary forms of medullary thyroid carcinoma.
    Rosenberg-Bourgin M; Gardet P; de Sahb R; Schlumberger M; Caillou B; Guilloud-Bataille M; Travagli JP; Feingold N; Parmentier C
    Henry Ford Hosp Med J; 1989; 37(3-4):141-3. PubMed ID: 2576948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for medullary cancer of the thyroid in France.
    Calmettes C
    Horm Metab Res Suppl; 1989; 21():1-2. PubMed ID: 2807149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary medullary thyroid carcinoma.
    Vasen HF; Vermey A
    Cancer Detect Prev; 1995; 19(2):143-50. PubMed ID: 7750101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A registry of medullary thyroid cancer in West Germany].
    Raue F; Späth-Röger M; Winter J; Benker G; Buhr P; Dorn R; Dralle H; Frilling A; Herrmann J; Hörnig I
    Med Klin (Munich); 1990 Mar; 85(3):113-6, 169. PubMed ID: 1970849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medullary cancer of the thyroid and multiple endocrine neoplastic syndromes].
    Delisle MJ
    Rev Prat; 1992 Apr; 42(7):845-50. PubMed ID: 1351314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medullary cancer of the thyroid].
    Calmettes C
    Bull Cancer; 1990; 77(11):1063-72. PubMed ID: 2275984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type II: clinical, biological and epidemiological features. French Medullary Study Group.
    Calmettes C
    Horm Res; 1989; 32(1-3):41-6. PubMed ID: 2575578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of screening for medullary thyroid carcinoma in families of patients with MEN 2.
    Frilling A; Goretzki PE; Bastian L; Roeher HD
    Henry Ford Hosp Med J; 1989; 37(3-4):122-3. PubMed ID: 2576942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preventive thyroidectomy in hereditary medullary thyroid gland carcinoma].
    Görtz G; Kress JH; Schmid KW
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():199-201. PubMed ID: 9101830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of medullary thyroid cancer.
    Sippel RS; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.
    Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
    Oncogene; 2006 Feb; 25(5):677-84. PubMed ID: 16205644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report.
    Menon MM; Simha MR
    Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medullary thyroid cancer--screening].
    Hansen HS
    Ugeskr Laeger; 1994 Jun; 156(26):3893-6. PubMed ID: 8059474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary medullary thyroid carcinoma in patients greater than 50 years old.
    Quayle FJ; Benveniste R; DeBenedetti MK; Wells SA; Moley JF
    Surgery; 2004 Dec; 136(6):1116-21. PubMed ID: 15657564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-genetic aspects of medullary thyroid cancer].
    Gar'kavtseva RF; Lisnianskiĭ IE
    Vopr Onkol; 1989; 35(6):663-8. PubMed ID: 2568716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.
    Guyétant S; Josselin N; Savagner F; Rohmer V; Michalak S; Saint-André JP
    Mod Pathol; 2003 Aug; 16(8):756-63. PubMed ID: 12920219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of families predisposed to cancer development in The Netherlands.
    Vasen HF; Griffioen G; Lips CJ; Struyvenberg A; van Slooten EA
    Anticancer Res; 1990; 10(2B):555-63. PubMed ID: 1972010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medullary carcinoma of the thyroid: diagnosis and therapy].
    Giuffrida D; Ferraù F; Bordonaro R; Mattina M; Priolo D; Aiello RA; Cordio S; Motta S; Failla G
    Clin Ter; 2000; 151(1):29-35. PubMed ID: 10822879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.